FDA approves first seasonal influenza vaccine manufactured using cell culture technology
FDA approves first seasonal influenza vaccine manufactured using cell culture technology The U.S. Food and Drug Administration announced today the approval of Flucelvax, the first seasonal influenza...
Data published in The Lancet show GlaxoSmithKline's Synflorix is highly effective at preventing invasive pneumococcal disease
Data published in The Lancet show GlaxoSmithKline's Synflorix is highly effective at preventing invasive pneumococcal disease Issued: Friday 16 November 2012, London, UK Results from the first...
European Medicines Agency recommends approval of first vaccine for meningitis B
European Medicines Agency recommends approval of first vaccine for meningitis B Vaccine to provide broad coverage against meningococcal group B infections The European Medicines Agency's Committee...
Novartis receives positive CHMP opinion for Bexsero(R), a groundbreaking vaccine to help prevent devastating MenB infections, the leading cause of meningitis in Europe
Novartis receives positive CHMP opinion for Bexsero(R), a groundbreaking vaccine to help prevent devastating MenB infections, the leading cause of meningitis in Europe Fri Nov 16, 2012 7:44am EST...
Argos Therapeutics Study Confirms Optimal Quality Control Methods for Production of its RNA-Based Immunotherapies
Argos Therapeutics Study Confirms Optimal Quality Control Methods for Production of its RNA-Based Immunotherapies RNA Analysis Data Published in Journal of Pharmaceutical and Biomedical Analysis...
European Medicines Agency recommends approval of first vaccine for meningitis B
European Medicines Agency recommends approval of first vaccine for meningitis B Vaccine to provide broad coverage against meningococcal group B infections 16/11/2012 The European Medicines...
Inovio Therapeutic Hepatitis B Vaccine Killer T Cells Demonstrate Potential to Clear HBV in Liver
Inovio Therapeutic Hepatitis B Vaccine Killer T Cells Demonstrate Potential to Clear HBV in Liver Inovio Advances New Disease Therapy, Where 400 Million Patients Lack Effective Treatment By Inovio...
RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants
RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants - Results from ongoing Phase III clinical trial announced Issued Friday 9 November 2012, London UK...
immatics' renal cancer vaccine IMA901 completes phase 3 patient recruitment and is granted US orphan drug designation by the FDA
immatics' renal cancer vaccine IMA901 completes phase 3 patient recruitment and is granted US orphan drug designation by the FDA Tuebingen, 08. November 2012 - immatics biotechnologies GmbH, a...
AgResearch Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development
AgResearch Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development Friday 2 November 2012 AgResearch announced today that it is a Grand Challenges...
Human clinical trials of HIV/AIDS vaccine making steady progress
Human clinical trials of HIV/AIDS vaccine making steady progress By Communications Staff Tuesday, November 6, 2012 London, Ontario CANADA –The first and only preventative HIV vaccine based on a...
BiondVax and MonoSol Rx to collaborate on developing oral delivery for universal flu vaccine, M-001.
BiondVax and MonoSol Rx to collaborate on developing oral delivery for universal flu vaccine, M-001. A material transfer agreement has been executed to allow sharing of patented technologies with the...
UK Government Awards £1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine
UK Government Awards £1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine 'OCTAVE' Study Will Assess ColoAd1 in Patients with Ovarian Cancer OXFORD,...
Clinical trials for first-ever human hookworm vaccine advance
Clinical trials for first-ever human hookworm vaccine advance Phase 1 clinical trial in Brazil begins testing at Brazilian field site WASHINGTON, D.C.—November 5, 2012—The Sabin Vaccine...
HPA awarded £4 million contract by US government to develop next generation anthrax vaccine
HPA awarded £4 million contract by US government to develop next generation anthrax vaccine 30 October 2012 The US Government, through the National Institute of Allergy and Infectious Diseases...
Novartis confident in safety and efficacy of its seasonal influenza vaccines produced in Italy
Novartis confident in safety and efficacy of its seasonal influenza vaccines produced in Italy As precaution, Italian ministry of health temporarily halts distribution of two seasonal influenza...
Developing New Vaccines for Emerging Diseases is Focus of $6.5 Million Contract
Developing New Vaccines for Emerging Diseases is Focus of $6.5 Million Contract Oct. 22, 2012 AUSTIN, Texas — Accelerating the evaluation and development of new vaccines for emerging health...
Anti-Cocaine Vaccine Combined with Immunovaccine's DepoVax™ Shows Promise in Exploratory Study
Anti-Cocaine Vaccine Combined with Immunovaccine's DepoVax™ Shows Promise in Exploratory Study DepoVax Platform Induces Antibodies that Block Cocaine Entry to Brain Halifax, Nova Scotia;...
Agenus Commences Phase 2 Study of HerpV Vaccine for the Treatment of Genital Herpes
Agenus Commences Phase 2 Study of HerpV Vaccine for the Treatment of Genital Herpes HerpV is the most clinically advanced therapeutic vaccine candidate for the treatment of genital herpes...
BiondVax is declared "a good manufacturing practice (GMP) Company" after passing European qualified person (QP) audit.
BiondVax is declared "a good manufacturing practice (GMP) Company" after passing European qualified person (QP) audit. BiondVax signs agreement to collaborate with MonoSol on developing oral delivery...
